Chiarugi A, Ceroti M, Palli D, Cevenini G, Guarrera M, Carli P
Department of Dermatology, University of Florence, Florence, Italy.
Clin Exp Dermatol. 2009 Jan;34(1):8-15. doi: 10.1111/j.1365-2230.2008.02836.x.
Sun sensitivity is one of the predictors of melanoma risk, together with other individual characteristics such as skin and eye colour and number of naevi. However, it is unclear how best to measure sun sensitivity in order to quantify the individual risk of melanoma.
In this case-control study, the relationship between minimal erythema dose (MED) and skin colour (both instrumentally assessed) was investigated, and their possible role as independent risk factors for melanoma in a Mediterranean population evaluated.
In total, 143 patients with cutaneous melanoma and 102 controls were enrolled in the study. Skin colour was assessed using a Minolta CR-200 chromameter. For MED calculation, a fluorescent lamp (Philips TL 4W/12) was used as a source of ultraviolet B light. MED was defined as the lowest dose that produced an increase of 2.5 in the redness value, expressed by the parameter a* of the Commission Internationale d'Eclairage (CIE) Lab* colour space (Deltaa* = 2.5).
A significant excess of risk was associated with increasing L* values of skin colour (P < 0.05; OR = 1.12; 95% CI 1.01-1.24) for each unit of change. Low MED values were also associated with an increasing risk of melanoma, with an excess of risk of 18% (OR = 1.18, 95% CI 1.04-1.35) for every 10 mJ/cm(2) of MED reduction. Compared with the highest MED values (> 97.7 mJ/cm(2)), subjects with MED values <or= 50 euro mJ/cm(2) or lower had a > 2-fold increased risk of melanoma (OR = 2.37, 95% CI 1.05-5.38). The effect of decreasing MED value as a melanoma risk factor persisted after adjustment for skin colour and atypical naevi in a multivariate model.
In conclusion, both instrumentally assessed skin colour and MED are significant risk factors for malignant melanoma in a Mediterranean population. MED seems be an independent variable in establishing the subject's risk profile.
日光敏感性是黑色素瘤风险的预测因素之一,与其他个体特征如肤色、眼睛颜色和痣的数量等共同起作用。然而,目前尚不清楚如何最好地测量日光敏感性以量化个体患黑色素瘤的风险。
在这项病例对照研究中,研究了最小红斑剂量(MED)与肤色(均通过仪器评估)之间的关系,并评估了它们作为地中海人群黑色素瘤独立危险因素的可能作用。
该研究共纳入了143例皮肤黑色素瘤患者和102例对照。使用美能达CR - 200色差仪评估肤色。计算MED时,使用荧光灯(飞利浦TL 4W/12)作为紫外线B光源。MED定义为使国际照明委员会(CIE)Lab颜色空间的参数a表示的发红值增加2.5时的最低剂量(Δa* = 2.5)。
肤色的L*值每变化一个单位,风险显著增加(P < 0.05;OR = 1.12;95% CI 1.01 - 1.24)。低MED值也与黑色素瘤风险增加相关,MED每降低10 mJ/cm²,风险增加18%(OR = 1.18,95% CI 1.04 - 1.35)。与最高MED值(> 97.7 mJ/cm²)相比,MED值≤50 μJ/cm²或更低的受试者患黑色素瘤的风险增加了2倍以上(OR = 2.37,95% CI 1.05 - 5.38)。在多变量模型中,调整肤色和非典型痣后,MED值降低作为黑色素瘤危险因素的作用仍然存在。
总之,通过仪器评估的肤色和MED都是地中海人群恶性黑色素瘤的重要危险因素。MED似乎是确定个体风险特征的一个独立变量。